Dear PAGE participants,
We gladly invite you to our one-and-a-half-day course, in which we will discuss
the importance of understanding the pharmacology of monoclonal antibodies
(mAbs) to make the right decisions in target-mediated drug disposition (TMDD)
model development.
After a short introduction, where we will directly dive into a hands-on
session, we’ll work in small groups on a TMDD modelling project using nlmixr2
within a shinyMixR workflow.
LAP&P’s interactive training will be held on Monday the 2nd of June 2025 (13 –
17) and Tuesday the 3rd of June (9-17) in Thessaloniki - Greece.
Find more information and register for the course on LAP&P course |
https://lapp.nl/lapp-course/ or on the PAGE website under Satellite
Meetings.
For questions, feel free to reach out to us.
Hope to see you there!
Tamara van Steeg
Tamara van Steeg, PhD
LAP&P Consultants
Leiden, The Netherlands
Web: http://www.lapp.nl/